<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00224315</url>
  </required_header>
  <id_info>
    <org_study_id>CZR-zink</org_study_id>
    <nct_id>NCT00224315</nct_id>
  </id_info>
  <brief_title>Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial</brief_title>
  <official_title>Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Institute of Mental Health, Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Institute of Mental Health, Mannheim</source>
  <brief_summary>
    <textblock>
      We aim to compare the augmentation of clozapine with ziprasidone or risperidone in a
      randomized, prospective manner.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Partial response of schizophrenic psychoses to a monotherapy with clozapine is a frequent
      problem of clinical psychiatry. Current problems are treatment resistant positive and/or
      negative symptoms, as well as side effects. Therefore, different strategies of augmentations
      have been applied. Based on successful experiences in case reports and results of other work
      groups, we aim to compare the augmentation of clozapine with ziprasidone or risperidone in a
      randomized, prospective manner.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date>September 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PANSS, SANS, HAMD, GAF, CGI, QTc</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body weight, EPMS, Akathisia,Prolactin, blood pressure, heart rate</measure>
  </secondary_outcome>
  <enrollment>24</enrollment>
  <condition>Schizophrenia, Schizoaffective Disorder</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ziprasidone</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>risperidone</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Treatment resistant schizophrenic or schizoaffective disorder under therapy with
             clozapine,

          -  Age between 18 and 70,

          -  Informed consent

        Exclusion Criteria:

          -  No informed consent,

          -  Intolerance with respect to ziprasidone or risperidone,

          -  Contraindications with respect to these substances,

          -  Gravidity or missing anticonceptive safety

          -  Substance dependance (excluded nicotin)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathias Zink, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Institute of Mental Health, Department of Psychiatry, Mannheim, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Institute of Mental Health, Department of Psychiatry,</name>
      <address>
        <city>Mannheim</city>
        <state>BW</state>
        <zip>68159</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2005</study_first_submitted>
  <study_first_submitted_qc>September 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>June 2, 2008</last_update_submitted>
  <last_update_submitted_qc>June 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2008</last_update_posted>
  <keyword>Schizophrenia,</keyword>
  <keyword>schizoaffective disorder,</keyword>
  <keyword>treatment resistancy</keyword>
  <keyword>clozapine,</keyword>
  <keyword>ziprasidone</keyword>
  <keyword>risperidone</keyword>
  <keyword>combination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Risperidone</mesh_term>
    <mesh_term>Ziprasidone</mesh_term>
    <mesh_term>Clozapine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

